Nicole Nevadunsky
Obstetrics & Gynecology · Bronx, NYNPI 1619131430
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,250 of the $5,053 with a category attached, or 64.3%. GSK accounts for 64.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,967 and has fallen 91.8% since, to $161 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $459.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- AstraZeneca$1K
- Intuitive Surgical$108
- Myriad Genetic Laboratories, Inc.$88
- Tesaro, Inc.$61
- Genmab U.S., Inc.$42
- plus $29 from 1 others
Across 156 payments — averaging $15,711 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$798K
- GSK$533K
- Astrazeneca UK Limited$349K
- Pfizer$301K
- Merck$283K
- Blueprint Medicines Corporation$159K
- plus $28K from 2 others
What the payments were for
- Consulting fees$3,25064%
- Grants$1,40528%
- Food & beverage$3377%
- Education$611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $3,250 |
| AstraZeneca | 3 | $1,475 |
| Intuitive Surgical | 2 | $108 |
| Myriad Genetic Laboratories, Inc. | 1 | $88 |
| Tesaro, Inc. | 1 | $61 |
| Genmab U.S., Inc. | 1 | $42 |
| Daiichi Sankyo Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$3,250
How this compares
$5,053 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 14 | $805 |
| Metronidazole | 20 | $713 |
| Gabapentin | 15 | $92 |
| Fluconazole | 30 | $92 |
| Oxycodone Hcl | 17 | $75 |
| Escitalopram Oxalate | 16 | $69 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Bronx
- Tia WelshBronx$24K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.